MYnd Analytics Inc (NASDAQ:MYAN) Director John Pappajohn bought 9,878 shares of the company’s stock in a transaction on Monday, April 3rd. The shares were acquired at an average price of $6.46 per share, with a total value of $63,811.88. Following the transaction, the director now directly owns 506,290 shares of the company’s stock, valued at $3,270,633.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Shares of MYnd Analytics Inc (NASDAQ:MYAN) remained flat at $6.00 during mid-day trading on Friday. MYnd Analytics Inc has a 12 month low of $2.80 and a 12 month high of $10.00. The stock has a 50-day moving average price of $6.64 and a 200 day moving average price of $8.09. The firm’s market capitalization is $13.80 million.
MYnd Analytics (NASDAQ:MYAN) last posted its quarterly earnings data on Tuesday, February 14th. The company reported ($0.70) EPS for the quarter. The business had revenue of $0.02 million for the quarter.
TRADEMARK VIOLATION WARNING: This piece was published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.chaffeybreeze.com/2017/04/21/mynd-analytics-inc-myan-director-john-pappajohn-purchases-9878-shares-of-stock-updated.html.
Separately, Maxim Group began coverage on MYnd Analytics in a research report on Friday, February 24th. They set a “buy” rating and a $18.00 target price for the company.
About MYnd Analytics
MYnd Analytics, Inc, formerly CNS Response, Inc, is a predictive analytics company. The Company has developed a decision support tool to help physicians reduce trial and error treatment in mental health, and provide personalized care to patients. The Company provides objective clinical decision support to mental healthcare providers for the personalized treatment of behavioral disorders, including depression, anxiety, bipolar disorder, post-traumatic stress disorder (PTSD) and other non-psychotic disorders.
Receive News & Ratings for MYnd Analytics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MYnd Analytics Inc and related companies with MarketBeat.com's FREE daily email newsletter.